Literature DB >> 12527654

Drug eluting stents: maximising benefit and minimising cost.

J Gunn1, A C Morton, C Wales, C M H Newman, D C Crossman, D C Cumberland.   

Abstract

A policy of selective implantation of drug eluting stents, in a minority of lesions most likely to benefit, seems to be a rational way to employ this new and currently costly technology.

Mesh:

Substances:

Year:  2003        PMID: 12527654      PMCID: PMC1767559          DOI: 10.1136/heart.89.2.127

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  14 in total

1.  Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter Ultrasound Stent In Coronaries.

Authors:  P W Serruys; I P Kay; C Disco; N V Deshpande; P J de Feyter
Journal:  J Am Coll Cardiol       Date:  1999-10       Impact factor: 24.094

2.  Bench to bedside: the development of rapamycin and its application to stent restenosis.

Authors:  S O Marx; A R Marks
Journal:  Circulation       Date:  2001-08-21       Impact factor: 29.690

3.  Does stent design affect the long-term outcome after coronary stenting?

Authors:  Meyer Elbaz; Elyes El Mokhtar; Joelle Fourcade; Sami Mourali; Robert Hobeika; Didier Carrié; Jacques Puel
Journal:  Catheter Cardiovasc Interv       Date:  2002-07       Impact factor: 2.692

4.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.

Authors:  P W Serruys; F Unger; J E Sousa; A Jatene; H J Bonnier; J P Schönberger; N Buller; R Bonser; M J van den Brand; L A van Herwerden; M A Morel; B A van Hout
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

5.  Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era.

Authors:  N Mercado; E Boersma; W Wijns; B J Gersh; C A Morillo; V de Valk; G A van Es; D E Grobbee; P W Serruys
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

6.  Procedural results and late clinical outcomes after percutaneous interventions using long (> or = 25 mm) versus short (< 20 mm) stents.

Authors:  R Kornowski; B Bhargava; S Fuchs; A J Lansky; L F Satler; A D Pichard; M K Hong; K M Kent; R Mehran; G W Stone; M B Leon
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

7.  Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up.

Authors:  J E Sousa; M A Costa; A C Abizaid; B J Rensing; A S Abizaid; L F Tanajura; K Kozuma; G Van Langenhove; A G Sousa; R Falotico; J Jaeger; J J Popma; P W Serruys
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

8.  Risk factors for the development of restenosis following stent implantation of venous bypass grafts.

Authors:  U E Heidland; M P Heintzen; C J Michel; B E Strauer
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

9.  Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents.

Authors:  R Hoffmann; G S Mintz; R Mehran; A D Pichard; K M Kent; L F Satler; J J Popma; H Wu; M B Leon
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

10.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.

Authors:  P W Serruys; P de Jaegere; F Kiemeneij; C Macaya; W Rutsch; G Heyndrickx; H Emanuelsson; J Marco; V Legrand; P Materne
Journal:  N Engl J Med       Date:  1994-08-25       Impact factor: 91.245

View more
  3 in total

1.  Intracoronary photodynamic therapy reduces neointimal growth without suppressing re-endothelialisation in a porcine model.

Authors:  R Waksman; I M Leitch; J Roessler; H Yazdi; R Seabron; F Tio; R W Scott; R I Grove; S Rychnovsky; B Robinson; R Pakala; E Cheneau
Journal:  Heart       Date:  2006-01-06       Impact factor: 5.994

2.  Targeting drug-eluting stents to lesions at high risk of restenosis: a flawed approach?

Authors:  A K Siotia; A C Morton; S Mofidi; C Wales; C Newman; J Gunn
Journal:  Heart       Date:  2007-02       Impact factor: 5.994

3.  Physician factors as an indicator of technological device adoption.

Authors:  LaToya C Artis; Theresa M Burkhart; Tricia J Johnson; Karl A Matuszewski
Journal:  J Med Syst       Date:  2006-06       Impact factor: 4.920

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.